Review



multitargeted antifolate pemetrexed alimta  (Eli Lilly)

 
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Eli Lilly multitargeted antifolate pemetrexed alimta
    Multitargeted Antifolate Pemetrexed Alimta, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multitarget+antifolate/antifolate+pemetrexed+alimta/pm12094334-6-4-5
    Average 90 stars, based on 1 article reviews
    multitargeted antifolate pemetrexed alimta - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: First assessment of whole-brain radiation therapy combined with pemetrexed-based chemotherapy in non-small-cell lung carcinoma
    Article Snippet: The folate antimetabolite pemetrexed was approved for the treatment of patients with metastatic nonsquamous non-small-cell lung carcinoma.. Its activity on brain metastases makes pemetrexed attractive in combination with whole-brain radiation therapy (WBRT), but it could also potentially increase toxicity.. We examined the medical records of 43 consecutive patients with brain metastases from non-small-cell lung carcinoma.

    Article Title: Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer
    Article Snippet: Taxanes and Histology Targeted therapies including bevacizumab, cetuximab, and the thymidylate synthase inhibitor pemetrexed (Alimta: Eli Lilly and Company, Indianapolis, IN, U.S.A.) have demonstrated benefit in some patient populations, but the observed benefit has been mixed and often dictated by histology 37 , 53 – 57 .

    Article Title: SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate.
    Article Snippet: However, recently a protocol was developed that describes the combined application of an antifolate (pemetrexed, Alimta; Eli Lilly & Co. (34)) and an organometallic 99mTcradiofolate that resulted in a significant and selective decrease of radioactivity retention in the kidneys without affecting the tumor uptake in mice (35).

    Activity Assay:

    Article Title: Developmental antiangiogenic agents for the treatment of non-small cell lung cancer (NSCLC).
    Article Snippet: Standard therapy for advanced or metastatic non-small cell lung cancer (NSCLC) has primarily consisted of traditional cytotoxic chemotherapy, although use of targeted therapies has been approved in specific settings.. Antiangiogenic agents represent a promising therapeutic strategy for treatment of advanced NSCLC.. Bevacizumab is currently approved when given in combination with firstline platinum-based therapy in selected patients with nonsquamous NSCLC.

    Article Title: Personalized medicine for non-small-cell lung cancer: implications of recent advances in tissue acquisition for molecular and histologic testing.
    Article Snippet: In light of recent advances in individualized therapy for non–small-cell lung cancer (NSCLC), molecular and histologic profiling is essential for guiding therapeutic decisions.. Results of these analyses may have implications for both response (eg, molecular testing for EGFR [epidermal growth factor receptor] mutations) and safety (eg, contraindications for squamous histology) in NSCLC.. Most patients with NSCLC present with unresectable advanced disease; therefore, greater emphasis is being placed on minimally invasive tissue acquisition techniques, such as small biopsy and cytology specimens.

    Mutagenesis:

    Article Title: Personalized medicine for non-small-cell lung cancer: implications of recent advances in tissue acquisition for molecular and histologic testing.
    Article Snippet: In light of recent advances in individualized therapy for non–small-cell lung cancer (NSCLC), molecular and histologic profiling is essential for guiding therapeutic decisions.. Results of these analyses may have implications for both response (eg, molecular testing for EGFR [epidermal growth factor receptor] mutations) and safety (eg, contraindications for squamous histology) in NSCLC.. Most patients with NSCLC present with unresectable advanced disease; therefore, greater emphasis is being placed on minimally invasive tissue acquisition techniques, such as small biopsy and cytology specimens.

    Injection:

    Article Title: In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
    Article Snippet: The overexpression of the folate receptor (FR) in a variety of malignant tumors, along with its limited expression in healthy tissues, makes it an attractive tumor-specific molecular target.. Noninvasive imaging of FR using radiolabeled folate derivatives is therefore highly desirable.. Given the advantages of positron emission tomography (PET) and the convenience of Ga production, the aim of our study was to develop a new Ga-folate-based radiotracer for clinical application.



    Similar Products

    90
    Eli Lilly multitargeted antifolate ly231514
    Multitargeted Antifolate Ly231514, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multitarget+antifolate/pemetrexed+alimta+ly231514/10__1021_slash_acs__orglett__0c01227-124-12-15
    Average 90 stars, based on 1 article reviews
    multitargeted antifolate ly231514 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    MultiTarget Pharmaceuticals pemetrexed multitarget antifolate
    Pemetrexed Multitarget Antifolate, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multitarget+antifolate/pemetrexed/pm24249036-196-21-21
    Average 90 stars, based on 1 article reviews
    pemetrexed multitarget antifolate - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    MultiTarget Pharmaceuticals multitarget antifolate
    <t> Gemcitabine </t> monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer
    Multitarget Antifolate, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multitarget+antifolate/multitarget+antifolate/pmc02907593-170-5-13
    Average 90 stars, based on 1 article reviews
    multitarget antifolate - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Eli Lilly multitargeted antifol (mta)
    <t> Gemcitabine </t> monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer
    Multitargeted Antifol (Mta), supplied by Eli Lilly, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multitarget+antifolate/multitargeted+antifol++mta+/pm14725732-75-0-9
    Average 90 stars, based on 1 article reviews
    multitargeted antifol (mta) - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Eli Lilly mta (multitargeted antifolate, ly231514, pemetrexed, alimta (n-[4-[2(2-amino-3,4-dihydro-4-oxo-7h-pyrrolo[2,3-d]pyrimidine-5-yl)ethyl]-benzoyl]-l-glutamic acid
    <t> Gemcitabine </t> monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer
    Mta (Multitargeted Antifolate, Ly231514, Pemetrexed, Alimta (N [4 [2(2 Amino 3,4 Dihydro 4 Oxo 7h Pyrrolo[2,3 D]Pyrimidine 5 Yl)ethyl] Benzoyl] L Glutamic Acid, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multitarget+antifolate/pemetrexed+alimta+ly231514/pm12494465-23-7-15
    Average 90 stars, based on 1 article reviews
    mta (multitargeted antifolate, ly231514, pemetrexed, alimta (n-[4-[2(2-amino-3,4-dihydro-4-oxo-7h-pyrrolo[2,3-d]pyrimidine-5-yl)ethyl]-benzoyl]-l-glutamic acid - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Eli Lilly multitargeted antifolate pemetrexed alimta
    <t> Gemcitabine </t> monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer
    Multitargeted Antifolate Pemetrexed Alimta, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multitarget+antifolate/antifolate+pemetrexed+alimta/pm12094334-6-4-5
    Average 90 stars, based on 1 article reviews
    multitargeted antifolate pemetrexed alimta - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Eli Lilly multitargeted antifolate ly231514 alimta
    <t> Gemcitabine </t> monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer
    Multitargeted Antifolate Ly231514 Alimta, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multitarget+antifolate/pemetrexed+alimta+ly231514/pm12057156-68-8-11
    Average 90 stars, based on 1 article reviews
    multitargeted antifolate ly231514 alimta - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    AstraZeneca ltd multitargeted antifolate mta
    <t> Gemcitabine </t> monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer
    Multitargeted Antifolate Mta, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multitarget+antifolate/multitargeted+antifolate+mta/pm12057154-67-11-7
    Average 90 stars, based on 1 article reviews
    multitargeted antifolate mta - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


     Gemcitabine  monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer

    Journal: Clinical Evidence

    Article Title: Pancreatic cancer

    doi:

    Figure Lengend Snippet: Gemcitabine monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer

    Article Snippet: , , Subgroup analysis , Gemcitabine monotherapy v gemcitabine plus other cytotoxic agent (multitarget antifolate, pemetrexed, or topoisomerase inhibitors irinotecan or exatecan) , Overall survival: 4 RCTs, 1404 people; HR 0.99; P = 0.80; no further data reported.

    Techniques:

    Gemcitabine monotherapy versus  gemcitabine-based  combinations for non-resectable (locally advanced or advanced) pancreatic cancer

    Journal: Clinical Evidence

    Article Title: Pancreatic cancer

    doi:

    Figure Lengend Snippet: Gemcitabine monotherapy versus gemcitabine-based combinations for non-resectable (locally advanced or advanced) pancreatic cancer

    Article Snippet: , , Subgroup analysis , Gemcitabine monotherapy v gemcitabine plus other cytotoxic agent (multitarget antifolate, pemetrexed, or topoisomerase inhibitors irinotecan or exatecan) , Overall survival: 4 RCTs, 1404 people; HR 0.99; P = 0.80; no further data reported.

    Techniques: